Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2010

01-06-2010 | Research Article

Community pharmacists’ perceptions of medicines use reviews and quality assurance by peer review

Authors: Geoffrey Harding, Michael Wilcock

Published in: International Journal of Clinical Pharmacy | Issue 3/2010

Login to get access

Abstract

Objectives To explore existing mechanism to ensure quality assurance of medicine use reviews (MURs), and to identify those parameters of an MUR that community pharmacists consider as indicators of quality. Setting Community pharmacists undertaking MURs in Cornwall, United Kingdom. Method A questionnaire was developed to investigate pharmacists’ attitudes towards MURs and towards quality assurance of MURs. Questionnaires were distributed during December 2008 to a sample of pharmacists in Cornwall accredited to provide the service. Main outcome measures Community pharmacists’ attitudes towards quality assurance of MURs. Results Fifty completed questionnaires were returned, a third of which were from locum pharmacists. The most frequently reported determinant for undertaking an MUR was the pharmacist’s judgement. Company policy to deliver MURs was acknowledged as a potential indicator of a sub-optimal MUR. Pharmacists shared a common sense of what constitutes a “poor” MUR but not what defines a quality one. Conclusion For peer review to operate as an effective mechanism to assure quality of MURs, pharmacists need to develop an effective forum to share their practice experiences.
Literature
2.
go back to reference Emblen G, Miller E. Home medicines review. The how and why for GPs. Aust Fam Physician. 2004;33:49–51.PubMed Emblen G, Miller E. Home medicines review. The how and why for GPs. Aust Fam Physician. 2004;33:49–51.PubMed
5.
go back to reference Bradley F, Wagner AC, Elvey R, Noyce PR, Ashcroft DM. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study. Health Policy. 2008;88:258–68.CrossRefPubMed Bradley F, Wagner AC, Elvey R, Noyce PR, Ashcroft DM. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study. Health Policy. 2008;88:258–68.CrossRefPubMed
6.
go back to reference Portlock J, Holden M, Patel S. A community pharmacy asthma MUR project in Hampshire and the Isle of Wight. Pharm J. 2009;282:109–12. Portlock J, Holden M, Patel S. A community pharmacy asthma MUR project in Hampshire and the Isle of Wight. Pharm J. 2009;282:109–12.
7.
go back to reference Murphy JA. Employers applying pressure to conduct MURs. Pharm J. 2007;279:258. Murphy JA. Employers applying pressure to conduct MURs. Pharm J. 2007;279:258.
8.
go back to reference Richards A. Medicine use review. Pharm J. 2008;280:750. Richards A. Medicine use review. Pharm J. 2008;280:750.
10.
go back to reference James DL, Hatten S, Roberts D, John DN. Identifying criteria for assessing the quality of medicines use review referral documentation by community pharmacists. Int J Pharm Pract. 2008;16:365–74.CrossRef James DL, Hatten S, Roberts D, John DN. Identifying criteria for assessing the quality of medicines use review referral documentation by community pharmacists. Int J Pharm Pract. 2008;16:365–74.CrossRef
11.
go back to reference Blenkinsopp A, Celino G, Bond C, Inch J. Medicine use reviews: the first year of a new community pharmacy contract. Pharm J. 2007;278:218–23. Blenkinsopp A, Celino G, Bond C, Inch J. Medicine use reviews: the first year of a new community pharmacy contract. Pharm J. 2007;278:218–23.
13.
go back to reference Harding G, Wilcock M. What do pharmacists think of peer review of medicines use reviews? Pharm J. 2008;281:674–6. Harding G, Wilcock M. What do pharmacists think of peer review of medicines use reviews? Pharm J. 2008;281:674–6.
14.
go back to reference Latif A, Boardman H. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30:536–43.CrossRefPubMed Latif A, Boardman H. Community pharmacists’ attitudes towards medicines use reviews and factors affecting the numbers performed. Pharm World Sci. 2008;30:536–43.CrossRefPubMed
15.
go back to reference Urban R, Rivers P, Morgan J. Perceptions of medicine use reviews—the views of community pharmacists within a West Yorkshire Primary Care Trust. Pharm J. 2008;281:303–5. Urban R, Rivers P, Morgan J. Perceptions of medicine use reviews—the views of community pharmacists within a West Yorkshire Primary Care Trust. Pharm J. 2008;281:303–5.
16.
go back to reference Bassi M, Wood K. Medicine use reviews: time for a new name? Int J Pharm Pract. 2009;17(Suppl 2):B4–5. Bassi M, Wood K. Medicine use reviews: time for a new name? Int J Pharm Pract. 2009;17(Suppl 2):B4–5.
17.
go back to reference Campion P, Hilton A, Irving G. Shared prescribing? A focus group study with community pharmacists. Prim Health Care Res Dev. 2007;8:308–14.CrossRef Campion P, Hilton A, Irving G. Shared prescribing? A focus group study with community pharmacists. Prim Health Care Res Dev. 2007;8:308–14.CrossRef
18.
go back to reference Gifford A, Murphy R, Anderson C. ‘Helpful others’: a vital resource for pharmacists’ learning? Int J Pharm Pract. 2008;16(Suppl 1):A9–A10. Gifford A, Murphy R, Anderson C. ‘Helpful others’: a vital resource for pharmacists’ learning? Int J Pharm Pract. 2008;16(Suppl 1):A9–A10.
19.
go back to reference Scwartzkoff J. Evaluation of the Home Medicines Review Program: pharmacy component. Canberra: Urbis Keys Young; 2005. Scwartzkoff J. Evaluation of the Home Medicines Review Program: pharmacy component. Canberra: Urbis Keys Young; 2005.
Metadata
Title
Community pharmacists’ perceptions of medicines use reviews and quality assurance by peer review
Authors
Geoffrey Harding
Michael Wilcock
Publication date
01-06-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9381-1

Other articles of this Issue 3/2010

International Journal of Clinical Pharmacy 3/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.